Gå direkt till innehåll

Ämnen: Farmaci

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis.

Amferia raises SEK 6.2 million in investment for innovative wound care patches that kill antibiotic resistant bacteria

​Almi Invest, Chalmers Ventures, along with the British investor Corithinan Properties Ltd. and Let’s Deal Founder Alexander Hars have invested a total of SEK 6.2 million in the Gothenburg-based med-tech company Amferia, who has developed a wound care product with a patented material that actively combats infections and kills antibiotic-resistant bacteria.

Welcome to Chalmers Ventures one of the leading tech investors in the Nordics.

Tech investor & venture builder. Taking deep tech from lab to market.

Chalmers Ventures

Vera Sandbergs Allé 8
412 96 Göteborg
Sverige